X4 Pharmaceuticals, Inc. (XFOR) — Stock Score Summary

X4 Pharmaceuticals, Inc. (XFOR) has a MoatMap StockRank of 35/100 based on Quality (27/100), Value (36/100), and Momentum (58/100) factor scores. The current signal is SELL. X4 Pharmaceuticals is a micro-cap biotech with binary clinical risk and no established commercial cash flows, failing our quality compounder criteria.

X4 Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to developing novel therapies for rare diseases, primarily those characterized by immune system dysfunction, utilizing its proprietary CXCR4 antagonist platform. The company's competitive edge is built on targeting high unmet medical needs in orphan disease populations, which can provide regulatory advantages and market exclusivity. X4 is a niche player focused on advancing precision medicines like its lead candidate, mavorixafor.

Key Financial Metrics

Price$3.85
Market Cap$390M
P/E (Forward)-4.39
Price/Book2.25
Return on Equity-104.2%
Return on Invested Capital-26.6%
Debt/Equity45.86
Gross Margin81.8%
Operating Margin-748.5%
Revenue Growth-90.6%
Free Cash Flow$-55M

X4 Pharmaceuticals, Inc. operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is X4 Pharmaceuticals, Inc.’s (XFOR) StockRank?
MoatMap’s StockRank for X4 Pharmaceuticals, Inc. (XFOR) is 35/100, with a Sell signal. It is a composite of Quality (27), Value (36), and Momentum (58) factor ranks across MoatMap’s 19,000+ stock universe.
Does X4 Pharmaceuticals, Inc. have an economic moat?
X4 Pharmaceuticals, Inc. (XFOR) has a Quality factor score of 27/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is X4 Pharmaceuticals, Inc. a buy, hold, or sell?
MoatMap’s current signal for X4 Pharmaceuticals, Inc. (XFOR) is Sell, based on a StockRank of 35/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is X4 Pharmaceuticals, Inc. in?
X4 Pharmaceuticals, Inc. (XFOR) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksXFOR deep dive reportAI ChampionsHow we score stocksSense-check another stock